期刊文献+

一次性同心圆针电极记录的单纤维肌电图对重症肌无力的诊断价值 被引量:1

The diagnostic value of single fiber electromyography recorded by single-use concentric needle electrodes in myasthenia gravis
下载PDF
导出
摘要 目的:探讨一次性同心圆针电极记录的单纤维肌电图(SFEMG)对重症肌无力(MG)的诊断价值。方法:将76例诊断为MG的患者及匹配正常对照组进行重复神经电刺激(RNS)、SFEMG、乙酰胆碱受体抗体(AChR-Ab)以及常规肌电图测定。结果:MG组jitter平均值(46.6±21.5)μs,jitter>42μs者平均(19.5±16.8)%,阻滞平均(5.3±10.2)%,均显著高于正常对照组(P<0.001);SFEMG异常的阳性率86.8%,RNS异常的阳性率34.2%,AChR-Ab异常的阳性率71.1%,SFEMG与RNS、AChR-Ab的阳性率差异均有统计学意义(P值均<0.005)。结论:一次性同心圆针电极记录SFEMG在MG的诊断中价值较高,对比于RNS、AChR-Ab,具有较高的阳性率,但需注意三者互补并结合临床表现来提高确诊率。 Objective:To evaluate the diagnostic value of single fiber electromyography recorded by single-use concentric needle electrodes in myasthenia gravis(MG).Methods:76 patients clinically diagnosed as myasthenia gravis and the matched control group were subjected to repetitive nerve stimulation(RNS),SFEMG,antibody to the acetylcholine receptor(AChRAb)and electromyography.Results:In the group of MG,the mean jitter ranged(46.6±21.5)μs,and the ratios of jitter>42μs and blocking were(19.5±16.8)%and(5.3±10.2)%respectively,which were all significantly higher than those in the control group(P<0.001).The abnormal positive rate of SFEMG,RNS and AChRAb was 86.8%,34.2%and 71.1%respectively,the difference being significant(P<0.005).Conclusion:The value of SFEMG recorded by single-use concentric needle electrodes in the diagnosis of MG is high.Compared with RNS and AChRAb,there was a higher positive rate,but the three should be complemented on the basis of clinical manifestations to improve the diagnosis rate.
作者 刘涓涓 彭燕妮 汪思佳 李才明 刘红英 陈礼锟 LIU Juanjuan;PENG yanni;WANG Sijia;LI Caiming;LIU Hongying;CHEN Likun(Department of Neuology,Huizhou First People's Hospital,Guangdong, Huizhou 516003,China)
出处 《包头医学院学报》 CAS 2019年第6期39-41,共3页 Journal of Baotou Medical College
关键词 一次性同心圆针电极 单纤维肌电图 重症肌无力 Single-use concentric needle Single fiber electromyography Myasthenia gravis
  • 相关文献

参考文献3

二级参考文献17

  • 1彭丹涛,许贤豪,佘子瑜.新斯的明试验改良结果判定法研究[J].中国神经免疫学和神经病学杂志,2007,14(1):1-3. 被引量:26
  • 2Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and tuture[J]. J Clin Invest, 2006, 116(11): 2843-2854.
  • 3Kerry E, Elsais A, Argov Z, et al. NE. EFNS/ENS Guidelines for the treatment of ocular myasthenia [ J ]. Eur J Neurol, 2014, 21(5) : 687-693.
  • 4Luehanok U, Kaminski HJ. Ocular myasthenia: diagnostic and treatment recommendations and the evidence basel[ J ]. Curr Opin Neurol, 2008, 21 ( 1 ) : 8-15.
  • 5Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for prevention and treatment[ J]. J Neurol Sci, 2007, 261 (1-2) : 127-133.
  • 6Meriggioli MN, Sanders DB. Autoimmune myasthcnia gravis: emerging clinical and biological heterogeneity[ J]. Lancet Neurol, 2009, 8(5) : 475-490.
  • 7Meyer DM, Herbert MA, Sobhani NC, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches[ J]. Ann Thorac Surg, 2009, 87(2) : 385-390.
  • 8Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders [ J ]. Eur J Neurol, 2010, 17(7) : 893-902.
  • 9Jani-Acsadi A, Lisak RP. Myasthenia gravis [ J ]. Curr Treat Options Neurol, 2010, 12 ( 3 ) : 231-243.
  • 10Kosmidis ML, Dalakas MC. Practical considerations on the use of rituximab in autoimmune neurological disorders [ J ].Ther Adv Neurol Disord, 2010, 3(2): 93-105.

共引文献301

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部